High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 90, Issue 2, 1996, Pages 179-181

  Ronn A M ^a   Msangeni, H A ^b   Mhina, J ^b   Wernsdorfer, W H ^c   Bygbjerg, I C ^a  

^a Rigshospitalet   (Denmark)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Drug resistance; Malaria; Plasmodium falciparum; Sulfadoxine pyrimethamine; Tanzania

Indexed keywords

AMODIAQUINE; CHLOROQUINE; DAPSONE; FANSIDAR; MALOPRIM;

ARTICLE; CHILD; CLINICAL TRIAL; FOLLOW UP; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; ORAL DRUG ADMINISTRATION; PARASITEMIA; PLASMODIUM FALCIPARUM; PROTOZOAL INFECTION; TANZANIA; TREATMENT OUTCOME;

EID: 0029877905     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(96)90129-7     Document Type: Article

References (10)

1. CDC [Centers for Disease Control] (1978). Chloroquine-resistant malaria acquired in Kenya and Tanzania - Denmark, Georgia, New York. Morbidity and Mortality Weekly Report, 27, 463-464.
2. Clyde, D. F. (1954). Observations on monthly pyrimethamine ('Daraprim') prophylaxis in an East African village. East African Medical Journal, 3, 41-46.
3. Clyde, D. F. & Shute, G. T. (1957). Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals. Transactions of the Royal Society of Tropical Medicine and Hygiene, 51, 505-513.
4. Draper, C. C., Brubaker, G., Geser, G., Kilimali, V. A. E. B. & Wernsdorfer, W. H. (1985). Serial studies on the evolution of chloroquine resistance in an area of East Africa receiving intermittent malaria chemosuppression. Bulletin of the World Health Organization, 63, 109-118.
5. Kilimali, V. A. E. B. & Mkufya, A. R. (1985). In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected. Transactions of the Royal Society of Tropical Medicine and Hygiene, 79, 482-483.
6. Petersen, E. (1987). In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulphamethoxazole, singly and in combination. Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 238-241.
7. Timmermanns, P. M., Hess, U. & Jones, M. E. (1982). Pyrimethamine/sulfadoxine resistant falciparum malaria in East Africa. Lancet, i, 1181.
8. Vleugels, M. P. H., Wetsteyn, J. C. F. M. & Meuwissen, J. H. E. T. (1982). Fansidar-resistant Plasmodium falciparum infection from Tanzania. Tropical and Geographical Medicine, 34, 263-265.
9. Wernsdorfer, W. H. (1991). The development and spread of drug resistant malaria. Parasitology Today, 7, 297-303.
10. WHO (1991). Basic Malaria Microscopy. Geneva: World Health Organization.